Berlin dismisses plan to issue emergency permit for German-made Curevac jab.

Berlin has quashed speculation it is to issue an emergency permit for the German-developed Curevac vaccine, insisting it will wait for approval from the European Medicines Agency (EMA).

Pressure to expedite the rollout of Curevac, based on similar mRNA technology to BioNTech, comes as the EU pivots away from traditional “vector” vaccine technology used in the AstraZeneca and Johnson & Johnson vaccines.

On Thursday Germany’s federal health minister Jens Spahn insisted he would wait for EMA approval on Curevac, expected in May or June. “There’s no data yet, so it’s not possible to issue an emergency permit.”

As a third wave of Covid-19 squeezes German intensive care capacity, almost 18 per cent of the population has been given at least one jab.

Similar to elsewhere in Europe, Germany’s vaccination schedule has been thrown into chaos by the indefinite suspension of the Johnson & Johnson rollout amid concerns over rare but serious blood clots.

Similar concerns have prompted Germany’s decision to restrict the AstraZeneca vaccine to over-60s.

Given these difficulties, Social Democratic (SPD) health spokesman Karl Lauterbach called for a national permit for Curevac, developed in Tübingen in southern Germany, as a way to ease “massive pressure” on the health service.

“If Curevac works similarly well to BioNTech or Moderna, which is to be expected, the vaccine should be approved as quickly as possible and deployed,” said Dr Lauterbach, a respected health expert and medical doctor. “Things take too long with EMA, as we saw with BioNTech.”

Genetic code

Similar to BioNTech and the US Moderna vaccine, Curevac is based on innovative messenger RNA (mRNA) technology. Unlike traditional “vector” vaccines, which deliver a harmless variant of the virus to trigger an immune response, mRNA vaccines deliver genetic code into human cells, instructing them to produce components of the targeted virus.

While the UK prioritised the AstraZeneca vector vaccine, co-developed with Oxford University, Germany’s federal government invested heavily in mRNA research and development of BioNTech and Curevac.

Last June Berlin took a 23 per cent stake in Curevac, through an investment of €300 million, and also provided €375 million in capital for BioNTech.

Though BioNTech was the first mRNA vaccine to market, Curevac scientists say its two-jab product is more flexible as it can be stored for three months at regular refrigerator temperatures.

After rebuffing a buy-out offer from the Trump administration last year, Curevac chief executive Franz-Werner Haas says its Europe-focused production and delivery will deliver 300 million doses this year and a billion next year.

Reliable partner

On Wednesday, European Commission president Ursula von der Leyen announced an additional 50 million BioNTech doses for the EU, and praised the Mainz-based company as a “reliable partner”.

Her commission would, she said, in future “focus on technologies that have proven their worth”.

A commission spokesperson declined to comment on reports on Thursday that next year Brussels will lapse its contracts with vector-vaccine producers Johnson & Johnson and AstraZeneca.

The Irish Times

The Irish Times online. Latest news including sport, analysis, business, weather and more from the definitive brand of quality news in Ireland.

https://www.irishtimes.com/

Rove: I was 'shocked' Biden pivoted from question on pipeline ransom.

Rove: I was 'shocked' Biden pivoted from question on pipeline ransom.

FOX News contributors Karl Rove and Katie Pavlich discuss Biden's foreign policy plans on 'Fox News Primetime.' #FoxNews #FoxNewsPrimetime Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 2...

1 33

Ted Cruz reacts to new CDC mask guidance: 'It's about damn time'.

Ted Cruz reacts to new CDC mask guidance: 'It's about damn time'.

Senator Ted Cruz discusses the CDC's new guidance on masks and rips Biden for his handling of mounting crises. Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24-hour all-encompassing news...

Yankees say 8 vaccinated team members tested positive for COVID.

Yankees say 8 vaccinated team members tested positive for COVID.

The New York Yankees say eight fully vaccinated team members have tested positive for COVID-19. CBSN is CBS News’ 24/7 digital streaming news service featuring live, anchored coverage available for free across all platforms. Launched in November 2...

WATCH: Video From Inside Israeli Home As Rocket Strikes Building.

WATCH: Video From Inside Israeli Home As Rocket Strikes Building.

Surveillance camera footage shows a resident of Petah Tikva relaxing in front of his TV when a rocket fired from Gaza explodes just outside his window. » Subscribe to NBC News: » Watch more NBC video: NBC News Digital is a collection of innovative...

Bill Hemmer reacts to latest 'woke' military recruitment ad.

Bill Hemmer reacts to latest 'woke' military recruitment ad.

'Gutfeld!' panel compares a United States Army ad to a Russian Armed Forces ad. #FoxNews #Gutfeld Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24-hour all-encompassing news service deli...

BREAKING: England's lockdown easing will go ahead despite Indian variant.

BREAKING: England's lockdown easing will go ahead despite Indian variant.

Vaccines Minister Nadhim Zahawi has told Sky News that restrictions in England will continue to be eased despite soaring cases of the Indian variant. However Mr Zahawi did not rule out local lockdowns. SUBSCRIBE to our YouTube channel for more vid...